{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:50:05Z","timestamp":1787500205626,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-025-00584-9","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T05:27:07Z","timestamp":1766813227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and evaluation of chitosan\u2013xanthan gum-based controlled release nanoparticles of mebeverine hydrochloride for targeted IBS therapy: in silico, in vitro, and in vivo investigations"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5896-4888","authenticated-orcid":false,"given":"V V Siva Krishna","family":"Pushadapu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3944-1869","authenticated-orcid":false,"given":"Grandhi","family":"Srikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.629026","volume":"11","author":"E Colomier","year":"2021","unstructured":"Colomier E, Algera J, Melchior C. Pharmacological therapies and their clinical targets in irritable bowel syndrome with diarrhea. Front Pharmacol. 2021;11:629026.","journal-title":"Front Pharmacol"},{"issue":"4","key":"584_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11041044","volume":"11","author":"J Daniluk","year":"2022","unstructured":"Daniluk J, Malecka-Wojciesko E, Skrzydlo-Radomanska B, Rydzewska G. The efficacy of mebeverine in the treatment of irritable bowel syndrome\u2014a systematic review. J Clin Med. 2022;11(4):1044.","journal-title":"J Clin Med"},{"key":"584_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jconrel.2024.01.025","volume":"364","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li J, Wu J. Colon-targeted nanoparticles for irritable bowel syndrome: mucoadhesive delivery of antispasmodics via biopolymer engineering. J Control Release. 2024;364:50\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.025.","journal-title":"J Control Release"},{"issue":"10","key":"584_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/apt.12907","volume":"40","author":"DA Drossman","year":"2014","unstructured":"Drossman DA, Tack J, Ford AC, et al. Quality of life in patients with irritable bowel syndrome (IBS), assessed using the IBS-Quality of life (IBS-QOL) measure after 4 and 8 weeks of treatment with Mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study. Aliment Pharmacol \\& Ther. 2014;40(10):1199\u2013209. https:\/\/doi.org\/10.1111\/apt.12907.","journal-title":"Aliment Pharmacol \\& Ther"},{"issue":"7","key":"584_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/polym15071596","volume":"15","author":"A Yusuf","year":"2023","unstructured":"Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems. Polymers. 2023;15(7):1596.","journal-title":"Polymers"},{"key":"584_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijbiomac.2022.01.162","volume":"203","author":"A Unknown","year":"2022","unstructured":"Gao Y, Wu Y. Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications. Int J Biol Macromol. 2022;203:379\u201388. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.162.","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"584_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810143","volume":"25","author":"B Layek","year":"2024","unstructured":"Layek B. A comprehensive review of xanthan gum-based oral drug delivery systems. Int J Mol Sci. 2024;25(18):10143. https:\/\/doi.org\/10.3390\/ijms251810143.","journal-title":"Int J Mol Sci"},{"key":"584_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120918","volume":"315","author":"M Liu","year":"2023","unstructured":"Liu M, Wang Y, Wang W. Advances in natural polysaccharide-based nanoparticle systems for oral drug delivery. Carbohydr Polym. 2023;315:120918. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120918.","journal-title":"Carbohydr Polym"},{"key":"584_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2024.112983","volume":"210","author":"A Haider","year":"2024","unstructured":"Haider A, Haider S, Kang IK. A comprehensive review of chitosan-based biomaterials for drug delivery and tissue engineering. Eur Polym J. 2024;210:112983. https:\/\/doi.org\/10.1016\/j.eurpolymj.2024.112983.","journal-title":"Eur Polym J"},{"issue":"4","key":"584_CR10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/pharmaceutics15041313","volume":"15","author":"N Desai","year":"2023","unstructured":"Desai N, Mali S, Shende P, Dhavale R. Chitosan: a potential biopolymer in drug delivery and biomedical applications. Pharmaceutics. 2023;15(4):1313. https:\/\/doi.org\/10.3390\/pharmaceutics15041313.","journal-title":"Pharmaceutics"},{"key":"584_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2023.105634","volume":"191","author":"A Harugade","year":"2023","unstructured":"Harugade A, Sherje AP, Pethe A. Chitosan: a review on properties, biological activities and recent progress in biomedical applications. React Funct Polym. 2023;191:105634.","journal-title":"React Funct Polym"},{"issue":"17","key":"584_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173981","volume":"25","author":"CP Jim\u00e9nez-G\u00f3mez","year":"2020","unstructured":"Jim\u00e9nez-G\u00f3mez CP, Cecilia JA. Chitosan: a natural biopolymer with a wide and varied range of applications. Molecules. 2020;25(17):3981.","journal-title":"Molecules"},{"issue":"2","key":"584_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020402","volume":"15","author":"M Jadav","year":"2023","unstructured":"Jadav M, Pooja D, Adams DJ, Kulhari H. Advances in xanthan gum-based systems for the delivery of therapeutic agents. Pharmaceutics. 2023;15(2):402.","journal-title":"Pharmaceutics"},{"issue":"31","key":"584_CR14","doi-asserted-by":"publisher","first-page":"16512","DOI":"10.1039\/D3RA03369D","volume":"13","author":"R Singh","year":"2023","unstructured":"Singh R, Khan FA, Tiwari S. Recent developments in natural biopolymer-based drug delivery systems. RSC Adv. 2023;13(31):16512\u201326. https:\/\/doi.org\/10.1039\/D3RA03369D.","journal-title":"RSC Adv"},{"issue":"45","key":"584_CR15","doi-asserted-by":"publisher","first-page":"27103","DOI":"10.1039\/D0RA04366D","volume":"10","author":"J Patel","year":"2020","unstructured":"Patel J, Maji B, Moorthy NSHN, Maiti S. Xanthan gum derivatives: review of synthesis, properties and diverse applications. RSC Adv. 2020;10(45):27103\u201336.","journal-title":"RSC Adv"},{"issue":"1","key":"584_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1080\/10717544.2022.2060476","volume":"29","author":"S Li","year":"2022","unstructured":"Li S, Zhang H, Chen K, Li J, Wang Z. Application of chitosan\/alginate nanoparticles in oral drug delivery systems: prospects and challenges. Drug Deliv. 2022;29(1):1142\u20139. https:\/\/doi.org\/10.1080\/10717544.2022.2060476.","journal-title":"Drug Deliv"},{"issue":"5","key":"584_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054289","volume":"24","author":"OR Guadarrama-Escobar","year":"2023","unstructured":"Guadarrama-Escobar OR, Cid-Becerra J, Morales-Ram\u00edrez J, Palacios-Gonz\u00e1lez B. Chitosan nanoparticles as oral drug carriers. Int J Mol Sci. 2023;24(5):4289. https:\/\/doi.org\/10.3390\/ijms24054289.","journal-title":"Int J Mol Sci"},{"key":"584_CR18","doi-asserted-by":"publisher","unstructured":"Haroon M, Rashid MA, Asghar W, editors. others. Mebeverine-loaded silver nanoparticles: in silico docking, spasmolytic and anti-inflammatory activity. Pharmaceutics. 2025;17(5):561. https:\/\/doi.org\/10.3390\/pharmaceutics17050561","DOI":"10.3390\/pharmaceutics17050561"},{"issue":"D1","key":"584_CR19","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202\u201313.","journal-title":"Nucleic Acids Res"},{"key":"584_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104550","volume":"83","author":"M Nasr","year":"2023","unstructured":"Nasr M, Mansour S, Fathy M. In silico modeling of drug delivery systems: applications in targeted gastrointestinal therapies. J Drug Deliv Sci Technol. 2023;83:104550. https:\/\/doi.org\/10.1016\/j.jddst.2022.104550.","journal-title":"J Drug Deliv Sci Technol"},{"key":"584_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106159","volume":"174","author":"DY Usta","year":"2022","unstructured":"Krishna PV, Babu PS, Hemalatha P, Susmitha MJ, Pujitha T, Raju SL, Ravi K. In vitro bio-equivalence studies on commercial formulations containing paracetamol and ibuprofen. Int J Pharm Sci Rev Res. 2023;79:199\u2013205.","journal-title":"Eur J Pharm Sci"},{"key":"584_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106159","volume":"174","author":"DY Usta","year":"2022","unstructured":"Usta DY, Timur B, Teksin ZS. Formulation development, optimization by Box\u2013Behnken design, and evaluation of a self-emulsifying drug delivery system. Eur J Pharm Sci. 2022;174:106159. https:\/\/doi.org\/10.1016\/j.ejps.2022.106159.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"584_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cgh.2023.01.015","volume":"22","author":"VC Goodoory","year":"2024","unstructured":"Goodoory VC, Almalki SM, Alhazmi HA, Alluhidan M, Alsharif MM. Efficacy of mesalazine in irritable bowel syndrome: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024;22(4):889\u2013900. https:\/\/doi.org\/10.1016\/j.cgh.2023.01.015.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"584_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060557","volume":"14","author":"S Noreen","year":"2021","unstructured":"Noreen S, Pervaiz F, Ashames A, et al. Optimization of novel naproxen-loaded chitosan\/carrageenan nanocarrier-based gel for topical delivery: Ex vivo, histopathological, and in vivo evaluation. Pharmaceuticals. 2021;14(6):557.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"584_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/polym10020174","volume":"10","author":"J Griesser","year":"2018","unstructured":"Griesser J, Het\u00e9nyi G, Bernkop-Schn\u00fcrch A. Hyaluronic acid thiomers: development and in vitro evaluation. Polymers (Basel). 2018;10(2):174. https:\/\/doi.org\/10.3390\/polym10020174.","journal-title":"Polymers (Basel)"},{"issue":"5","key":"584_CR26","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1021\/acs.biomac.1c00190","volume":"22","author":"C Kurpiers","year":"2021","unstructured":"Kurpiers C, Griesser J, Bernkop-Schn\u00fcrch A. Thiolated chitosans: a multi-talented class of polymers for various applications. Biomacromolecules. 2021;22(5):1954\u201372. https:\/\/doi.org\/10.1021\/acs.biomac.1c00190.","journal-title":"Biomacromolecules"},{"issue":"3","key":"584_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2008.02.007","volume":"128","author":"N Anton","year":"2008","unstructured":"Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates\u2014a review. J Control Release. 2008;128(3):185\u201399.","journal-title":"J Control Release"},{"issue":"1","key":"584_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0927-7757(98)00207-6","volume":"141","author":"MR Gittings","year":"1998","unstructured":"Gittings MR, Saville DA. The determination of hydrodynamic size and zeta potential from electrophoretic mobility and light scattering measurements. Colloids Surf Physicochem Eng Asp. 1998;141(1):111\u20137.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"issue":"2","key":"584_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejpb.2008.01.013","volume":"69","author":"X Song","year":"2008","unstructured":"Song X, Zhao Y, Hou S, et al. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm. 2008;69(2):445\u201353.","journal-title":"Eur J Pharm Biopharm"},{"issue":"17","key":"584_CR30","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3109\/03639049409042679","volume":"20","author":"MA Bayomi","year":"1994","unstructured":"Bayomi MA, Al-Angary AA, Al-Meshal MA, El-Mahrouk GM. Preparation and dissolution characteristics of prolonged release mebeverine-HCl beads. Drug Dev Ind Pharm. 1994;20(17):2763\u201373.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"584_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030745","volume":"15","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, El-Nabarawi MA, Shamma RN. Design and evaluation of Mebeverine HCl loaded Eudragit nanoparticles: improved release and colon-specific targeting. Pharmaceutics. 2023;15(3):745. https:\/\/doi.org\/10.3390\/pharmaceutics15030745.","journal-title":"Pharmaceutics"},{"key":"584_CR32","doi-asserted-by":"publisher","unstructured":"Eid MM. Characterization of nanoparticles by FTIR and FTIR-microscopy. In: Nalwa HS, Webster TJ, editors. Handbook of Consumer Nanoproducts. Singapore: Springer. 2022; p. 1\u201330. https:\/\/doi.org\/10.1007\/978-981-16-4641-2_27.","DOI":"10.1007\/978-981-16-4641-2_27"},{"key":"584_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106401","volume":"196","author":"V Tiwari","year":"2024","unstructured":"Tiwari V, Dey P, Patra B. Preclinical evaluation of polymeric nanoparticles for IBS: pharmacodynamic and behavioral correlation in rat models. Eur J Pharm Sci. 2024;196:106401. https:\/\/doi.org\/10.1016\/j.ejps.2024.106401.","journal-title":"Eur J Pharm Sci"},{"key":"584_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1039804","volume":"13","author":"Z Zhuang","year":"2022","unstructured":"Zhuang Z, Huang C, Zhang Y, Lv B. Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome. Front Physiol. 2022;13:1039804.","journal-title":"Front Physiol"},{"issue":"1","key":"584_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91883-3","volume":"15","author":"H Fan","year":"2025","unstructured":"Fan H, Zhan Y, Cheng X, et al. Lacidophilin tablets relieve irritable bowel syndrome in rats by regulating gut microbiota dysbiosis and intestinal inflammation. Sci Rep. 2025;15(1):8151.","journal-title":"Sci Rep"},{"issue":"1","key":"584_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/polym15010228","volume":"15","author":"H Choudhury","year":"2023","unstructured":"Choudhury H, Pandey M, Lim YH, Cheah YK, Pichika MR. others. Formulation, optimization and evaluation of Xanthan gum-based mucoadhesive buccal patches. Polym (Basel). 2023;15(1):228. https:\/\/doi.org\/10.3390\/polym15010228.","journal-title":"Polym (Basel)"},{"key":"584_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.114407","volume":"205","author":"A Gautam","year":"2025","unstructured":"Gautam A, Alqahtani A, Kesharwani P. Sustained-release oral delivery systems: are nanocarriers the future beyond tablets? Adv Drug Deliv Rev. 2025;205:114407. https:\/\/doi.org\/10.1016\/j.addr.2025.114407.","journal-title":"Adv Drug Deliv Rev"},{"key":"584_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jconrel.2022.12.010","volume":"343","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin Y, Han Y, Zhou Y, Zhang Z. Amorphous drug-loaded chitosan nanoparticles improve solubility and bioavailability. J Control Release. 2022;343:647\u201359. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.010.","journal-title":"J Control Release"},{"key":"584_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1039804","volume":"14","author":"Z Zhuang","year":"2023","unstructured":"Zhuang Z, Huang C, Zhang Y, Lv B. Colon-targeted delivery of curcumin using polysaccharide-based nanoparticles in IBS models. Front Physiol. 2023;14:1039804. https:\/\/doi.org\/10.3389\/fphys.2023.1039804.","journal-title":"Front Physiol"},{"key":"584_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120143","volume":"299","author":"J Patel","year":"2023","unstructured":"Patel J, Gandhi R, Desai P. Microbiota-targeted delivery systems using fermentable polysaccharides for IBS therapy. Carbohydr Polym. 2023;299:120143. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120143.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"584_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01829-2","volume":"21","author":"M Bhatia","year":"2023","unstructured":"Bhatia M, Ahuja M, Singh SK. Chitosan-based nanocarriers in preclinical models of colitis and IBS: targeting intestinal inflammation. J Nanobiotechnology. 2023;21(1):34. https:\/\/doi.org\/10.1186\/s12951-023-01829-2.","journal-title":"J Nanobiotechnology"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00584-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-025-00584-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00584-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:05:46Z","timestamp":1780113946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-025-00584-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s40199-025-00584-9","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animals utilized in the study included Wistar rats. The study protocol was approved by the Institutional Animal Ethics Committee, Vignan Pharmacy College, Guntur, India, with approval number IAEC\/VPCV\/24\u201325\/3.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}